Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1993-4-8
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1058-4838
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
335
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7680238-Hepacivirus,
pubmed-meshheading:7680238-Hepatitis Antibodies,
pubmed-meshheading:7680238-Hepatitis C,
pubmed-meshheading:7680238-Hepatitis C Antibodies,
pubmed-meshheading:7680238-Humans,
pubmed-meshheading:7680238-Immunoglobulins,
pubmed-meshheading:7680238-Occupational Exposure
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Administration of immune serum globulin following exposure to hepatitis C virus.
|
| pubmed:publicationType |
Letter,
Comment
|